Our mission is to pioneer cell therapies for clinical application. Our vision is to improve the human condition through functional cures by bioengineered cell transplantation.
Pioneering Cell TherapiesTM
Advancing cell therapies from concept to benchside to clinic.
CellTrans provides world-class services for autologous and allogeneic islet isolations for the purpose of clinical transplantation.
Includes contract research ranging from proof of concept to planning and execution of IND/IDE enabling pre-clinical testing.
CellTrans has unique expertise in complex in vitro cell product assessments. We can help you develop batch release testing for your cellular product.
Meet the CellTrans Team.
Prior to CellTrans, Dr. McGarrigle served as Assistant Research Professor at the University of Illinois at Chicago, in the Department of Surgery, evaluating various cell therapies and biomaterial products to combat diabetes, as well as research projects aimed to improve and better assess human islet manufacture and transplantation. Earned bachelor’s degree in Microbiology and Biochemistry and a PhD in Microbiology, both from the National University of Ireland, Galway.
In her free time, Quetzalli enjoys reading medical memoirs and spending time with her family.
Fun Fact: Sharon collects antiques that included novels and music boxes dating back to the 1800s.
Research focused on achieving a functional cure for Type I diabetes through islet transplantation
Research focused on microencapsulation of islets to prevent immunorejection and achieve long-term islet graft
Research focused on bioengineering of microfluidic biochips to study beta-cell physiology